| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K03536150 |
| PharmacoGx | BRD-K03536150 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RNASE3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | PMS2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | MTRR | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | IGSF9 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | NSL1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | ATOH7 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | FCGR1B | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | KLHL8 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | FYTTD1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SLC25A19 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
